Cognyte Software Ltd. Operating Income 2011-2026 | CGNT

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Cognyte Software Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-5.13 M	-18.1 M	-103 M	11 M	18.3 M	27.3 M	18.7 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
27.3 M	-103 M	-7.32 M

Operating Income of other stocks in the Medical devices industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Allied Healthcare Products AHPI	-1.27 M	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	-31.4 M	-	-	$ 475 M	USA
Acutus Medical AFIB	-11.7 M	-	-26.83 %	$ 2.62 M	USA
Axonics Modulation Technologies AXNX	-64.9 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	-30.5 M	-	1.37 %	$ 20.5 M	USA
Apyx Medical Corporation APYX	-17.3 M	$ 3.97	-	$ 137 M	USA
Alphatec Holdings ATEC	-136 M	$ 13.48	-4.13 %	$ 1.93 B	USA
BIOLASE BIOL	-17.9 M	-	-13.19 %	$ 166 K	USA
EDAP TMS S.A. EDAP	-20.5 M	$ 4.08	0.37 %	$ 152 M	France
Bio-Rad Laboratories BIO	269 M	$ 299.07	-2.23 %	$ 8.44 B	USA
Bruker Corporation BRKR	253 M	$ 41.06	-3.54 %	$ 6.12 K	USA
BioSig Technologies BSGM	-12.9 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	2.6 B	$ 78.26	3.65 %	$ 115 B	USA
Abbott Laboratories ABT	6.82 B	$ 109.11	0.84 %	$ 190 B	USA
Conformis CFMS	-46.3 M	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	-19.7 M	$ 12.43	-6.61 %	$ 336 M	USA
CONMED Corporation CNMD	200 M	$ 40.63	1.75 %	$ 1.25 B	USA
Cardiovascular Systems CSII	-35.8 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	-156 M	-	-10.19 %	$ 1.99 M	USA
Neovasc NVCN	-31.1 M	-	-	$ 111 M	Canada
Dynatronics Corporation DYNT	-2.45 M	-	14.99 %	$ 929 K	USA
Eargo EAR	-112 M	-	-	$ 10.2 M	USA
Electromed ELMD	9.66 M	$ 28.95	-0.96 %	$ 245 M	USA
InMode Ltd. INMD	113 M	$ 14.77	-1.66 %	$ 1.17 B	Israel
GBS GBS	-10.6 M	-	-0.57 %	$ 7.12 M	USA
Second Sight Medical Products EYES	-24.7 M	-	-0.97 %	$ 54.4 M	USA
Profound Medical Corp. PROF	-30.3 M	$ 6.35	-6.89 %	$ 180 M	Canada
Align Technology ALGN	608 M	$ 176.77	9.59 %	$ 13.2 B	USA
Avinger AVGR	-16.6 M	-	-20.74 %	$ 369 K	USA
FONAR Corporation FONR	5.31 M	$ 18.54	0.11 %	$ 122 M	USA
Globus Medical GMED	166 M	$ 87.55	0.56 %	$ 11.9 B	USA
Integra LifeSciences Holdings Corporation IART	28.4 M	$ 10.94	-1.26 %	$ 842 M	USA
Establishment Labs Holdings ESTA	-50 M	$ 66.7	-3.52 %	$ 1.88 B	Costa-rica
IRIDEX Corporation IRIX	-10 M	$ 1.45	0.69 %	$ 23.4 M	USA
IRadimed Corporation IRMD	22 M	$ 94.23	0.4 %	$ 1.19 B	USA
Integer Holdings Corporation ITGR	208 M	$ 85.94	0.49 %	$ 2.89 B	USA
Invacare Corporation IVC	-80.5 M	-	-	$ 24.7 M	USA
Cytosorbents Corporation CTSO	-16.8 M	$ 0.67	0.3 %	$ 36.5 M	USA
OrthoPediatrics Corp. KIDS	-35 M	$ 16.64	-1.54 %	$ 384 M	USA